
两位接近赢创(EVKn.DE)的消息人士周三向路透社表示,巴斯夫(BASFn.DE)在纸面上提高报价将不足以实现对赢创的收购。消息人士称,达成交易需要令人信服的工业逻辑理由。
A higher offer on paper from BASF (BASFn.DE) will not be enough for a takeover of Evonik (EVKn.DE), two sources close to Evonik told Reuters on Wednesday. There would need to be a compelling industrial rationale for a deal, the sources said.
路透社看到的一份内部备忘录显示,赢创管理层告诉员工,依然坚信公司作为独立企业拥有强劲的未来。
In an internal memo seen by Reuters, Evonik's management told employees it remained convinced the company had a strong future as an independent business.
此前,德国商业出版物《商报》(Handelsblatt)援引金融业消息人士报道称,巴斯夫需要大幅提高对较小同行赢创的报价,每股26欧元至28欧元(约合29美元至31美元)的出价可能有助于打破僵局。赢创和巴斯夫均拒绝就该报道置评。
The news comes after German business publication Handelsblatt, citing financial industry sources, reported that BASF would need to significantly raise its offer for smaller peer Evonik, with a bid of €26 to €28 ($29 to $31) per share potentially helping to break the deadlock. Evonik and BASF declined to comment on the report.